Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00069849
Status:
TERMINATED
Last Update Posted:
2006-09-04
First Post:
2003-10-01
Brief Title:
A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimers Disease
Sponsor:
Abbott
Organization:
Abbott
Study Overview
Official Title:
A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimers Disease
Status:
TERMINATED
Status Verified Date:
2006-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the safety and efficacy of 2 mg 4 mg and 20 mg of ABT-089 BID to placebo in adults with Alzheimers disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None